LJ 102

Drug Profile

LJ 102

Alternative Names: HER 102; LJ-102

Latest Information Update: 29 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Hervana
  • Class Contraceptives
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Pregnancy

Most Recent Events

  • 28 Sep 2013 Preclinical trials in Pregnancy (Prevention) in Israel (Vaginal, Bi-monthly)
  • 28 Sep 2013 Preclinical trials in Pregnancy (Prevention) in Israel (Vaginal, Once-monthly)
  • 12 May 2010 Early research in Pregnancy (Prevention) in Israel (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top